These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 27696432)

  • 1. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of perioperative inflammatory-based prognostic systems in patients with colorectal liver metastases undergoing surgery. A cohort study.
    Solaini L; Atmaja BT; Arumugam P; Hutchins RR; Abraham AT; Bhattacharya S; Kocher HM
    Int J Surg; 2016 Dec; 36(Pt A):8-12. PubMed ID: 27742565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival.
    Kobayashi T; Teruya M; Kishiki T; Endo D; Takenaka Y; Miki K; Kobayashi K; Morita K
    Dig Surg; 2010; 27(4):285-90. PubMed ID: 20689289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases.
    Nakagawa K; Tanaka K; Nojiri K; Kumamoto T; Takeda K; Ueda M; Endo I
    Ann Surg Oncol; 2014 May; 21(5):1711-8. PubMed ID: 24452408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases.
    Haruki K; Shiba H; Horiuchi T; Sakamoto T; Gocho T; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
    Am J Surg; 2017 Oct; 214(4):752-756. PubMed ID: 28187858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the Glasgow Prognostic Score for patients with colorectal liver metastasis.
    Okimoto S; Kobayashi T; Tashiro H; Kuroda S; Ishiyama K; Ide K; Abe T; Hashimoto M; Iwako H; Hamaoka M; Honmyo N; Yamaguchi M; Ohdan H
    Int J Surg; 2017 Jun; 42():209-214. PubMed ID: 28483664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Post-operative Serum C-reactive Protein Level for -Survival after Surgery for Colorectal Liver Metastases.
    van der Stok EP; Grünhagen DJ; Rothbarth J; Verhoef C
    Acta Chir Belg; 2015; 115(5):348-55. PubMed ID: 26560001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of C-reactive Protein-To-Lymphocyte Ratio in Colorectal Liver Metastases.
    Taniai T; Haruki K; Hamura R; Fujiwara Y; Furukawa K; Gocho T; Shiba H; Yanaga K
    J Surg Res; 2021 Feb; 258():414-421. PubMed ID: 33109402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.
    Neal CP; Mann CD; Garcea G; Briggs CD; Dennison AR; Berry DP
    Arch Surg; 2011 Apr; 146(4):471-8. PubMed ID: 21502458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined evaluation of the Glasgow prognostic score and carcinoembryonic antigen concentration prior to hepatectomy predicts postoperative outcomes in patients with liver metastasis from colorectal cancer.
    Kobayashi T; Kawakamil M; Hara Y; Shioiri S; Yasuno M; Teruya M; Kaminishi M
    Hepatogastroenterology; 2014; 61(133):1359-62. PubMed ID: 25436311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
    Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein (CRP) as a prognostic factor for colorectal cancer after surgical resection of pulmonary metastases.
    Li C; Xu Q; Chen L; Luo C; Ying J; Liu J
    Bull Cancer; 2017 Mar; 104(3):232-236. PubMed ID: 28063672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.